BACKGROUND: E-cadherin is a cell adhesion protein with crucial roles in development, tissue homeostasis, and disease. Loss of E-cadherin in the adult intestinal epithelium disrupts tissue architecture and is associated with impaired localization and function of goblet and Paneth cells, reduced expression of antibacterial factors, and deficiency in clearing enteropathogenic bacteria. Several studies have suggested a role of E-cadherin in human inflammatory bowel disease. AIM: To investigate the role of E-cadherin deficiency in the pathogenesis of inflammatory bowel disease in a mouse model of experimentally induced colitis. METHODS: To induce E-cadherin deficiency, Villin-Cre-ER (T2) ;Cdh1 (fl/fl) mice received intraperitoneal injections of tamoxifen at days 1, 2, 5, and 8. Experimental colitis was induced by oral administration of dextran sodium sulfate (DSS, 3.5 % in the drinking water) for 3 days, starting at the third day after the first tamoxifen injection. RESULTS: E-cadherin deficiency in the adult mouse intestinal epithelium aggravates the clinical and histological features of DSS-induced colitis. Upon DSS treatment, mice deficient in E-cadherin lost more weight, were more severely dehydrated, and showed more frequently blood in the feces. Histologically, intestinal E-cadherin deficiency was associated with exacerbated acute and chronic inflammation and increased regenerative epithelial changes. Finally, the changes in the epithelium were distributed more diffusely in E-cadherin-deficient mice, while the mucosal damage was more focally localized in control animals. CONCLUSIONS: Our findings suggest that E-cadherin may play an important role in the pathogenesis of ulcerative colitis, one of the major clinical forms of inflammatory bowel disease.
BACKGROUND:E-cadherin is a cell adhesion protein with crucial roles in development, tissue homeostasis, and disease. Loss of E-cadherin in the adult intestinal epithelium disrupts tissue architecture and is associated with impaired localization and function of goblet and Paneth cells, reduced expression of antibacterial factors, and deficiency in clearing enteropathogenic bacteria. Several studies have suggested a role of E-cadherin in humaninflammatory bowel disease. AIM: To investigate the role of E-cadherin deficiency in the pathogenesis of inflammatory bowel disease in a mouse model of experimentally induced colitis. METHODS: To induce E-cadherin deficiency, Villin-Cre-ER (T2) ;Cdh1 (fl/fl) mice received intraperitoneal injections of tamoxifen at days 1, 2, 5, and 8. Experimental colitis was induced by oral administration of dextran sodium sulfate (DSS, 3.5 % in the drinking water) for 3 days, starting at the third day after the first tamoxifen injection. RESULTS:E-cadherin deficiency in the adult mouse intestinal epithelium aggravates the clinical and histological features of DSS-induced colitis. Upon DSS treatment, mice deficient in E-cadherin lost more weight, were more severely dehydrated, and showed more frequently blood in the feces. Histologically, intestinal E-cadherin deficiency was associated with exacerbated acute and chronic inflammation and increased regenerative epithelial changes. Finally, the changes in the epithelium were distributed more diffusely in E-cadherin-deficient mice, while the mucosal damage was more focally localized in control animals. CONCLUSIONS: Our findings suggest that E-cadherin may play an important role in the pathogenesis of ulcerative colitis, one of the major clinical forms of inflammatory bowel disease.
Authors: P Demetter; M De Vos; N Van Damme; D Baeten; D Elewaut; S Vermeulen; M Mareel; G Bullock; H Mielants; G Verbruggen; F De Keyser; E M Veys; C A Cuvelier Journal: Am J Clin Pathol Date: 2000-09 Impact factor: 2.493
Authors: Jan Wehkamp; Nita H Salzman; Edith Porter; Sabine Nuding; Michael Weichenthal; Robert E Petras; Bo Shen; Elke Schaeffeler; Matthias Schwab; Rose Linzmeier; Ryan W Feathers; Hiutung Chu; Heriberto Lima; Klaus Fellermann; Tomas Ganz; Eduard F Stange; Charles L Bevins Journal: Proc Natl Acad Sci U S A Date: 2005-12-05 Impact factor: 11.205
Authors: Marlon R Schneider; Felix Hiltwein; Jessica Grill; Helmut Blum; Stefan Krebs; Andrea Klanner; Stefan Bauersachs; Christiane Bruns; Thomas Longerich; David Horst; Lydia Brandl; Enrico de Toni; Andreas Herbst; Frank T Kolligs Journal: Carcinogenesis Date: 2014-05-19 Impact factor: 4.944
Authors: J A Jankowski; F K Bedford; R A Boulton; N Cruickshank; C Hall; J Elder; R Allan; A Forbes; Y S Kim; N A Wright; D S Sanders Journal: Lab Invest Date: 1998-09 Impact factor: 5.662
Authors: Karthikeyani Chellappa; Poonamjot Deol; Jane R Evans; Linh M Vuong; Gang Chen; Nadege Briançon; Eugene Bolotin; Christian Lytle; Meera G Nair; Frances M Sladek Journal: Elife Date: 2016-05-11 Impact factor: 8.140
Authors: Kevin T Kline; Haifeng Lian; Xiaoying S Zhong; Xiuju Luo; John H Winston; Yingzi Cong; Tor C Savidge; Roderick H Dashwood; Don W Powell; Qingjie Li Journal: J Immunol Date: 2019-12-30 Impact factor: 5.422
Authors: Eleni Christodoulou-Vafeiadou; Fotis Ioakeimidis; Margarita Andreadou; Giorgos Giagkas; George Stamatakis; Martin Reczko; Martina Samiotaki; Anastasios D Papanastasiou; Ioannis Karakasiliotis; Dimitris L Kontoyiannis Journal: Front Immunol Date: 2018-11-23 Impact factor: 7.561